Jump to Main Contents
ncc en

Annual Report 2020

Department of Nursing

Fukuko Oshiba, Asuko Sekimoto, Ayako Mori, Hiroko Nakahama, Maki Kimura, Aya Oya, Chiemi Kojima, Naoko Okada, Yumiko Arai, Tomomi Mochizuki, Akemi Komiyama, Kyomi Maruyama, Mieko Machida, Kyoko Suzuki, Kumi Yoshimura, Miki Izumi, Akemi Yamada, Yuka Morohashi, Nozomi Asai, Michiko Oki, Makiko Suzuki, Kazumi Ishii, Miki Hosoya, Yuko Hirose, Mihoko Asanabe, Emi Fujii, Yuri Nakamura, Hiroko Sasaguchi, Naoko Haji, Chiaki Ito

Introduction

 The Department of Nursing bears responsibility for team healthcare at the National Cancer Center Hospital (NCCH), the core institution for national cancer treatment and control in Japan. With our motto, “All Activities for Cancer Patients”, the responsibility of our department is to develop and improve the quality of cancer nursing as well as to contribute to the appropriate management of the hospital. Our department is also expected to foster nursing staff to achieve the best cancer nursing possible.

The Team and What We Do

 We have opened a COVID-19 unit in April and an fever outpatient center in September, fulfilling our role as part of a team by proper staffing and creating/updating business procedures for the infection control to be done in safety.

 On the other hand, we did not let up on cancer treatment during the COVID-19 pandemic, and we worked to improve the medical treatment and recuperation environment and provide education so that cancer patients could receive treatment safely and securely.

 We effectively deployed nurse specialists/certified nurses to support cancer patients' decision making in choosing their treatment and care environment.

 To meet the diverse needs of cancer patients, we collaborate with multiple professions to establish a support system for admission and discharge from the hospital, support for convalescent life, and community medical care coordination.

Research activities

 We presented 43 nursing studies at several annual conferences in 2020, and a number of practical reports on the work of nurses, particularly cancer nursing, such as ACP and relations with AYA generation.

 In addition, we published 12 journal articles and books that reflect our nursing practice.

Human resource development and Education

 In FY2020, two nurses were designated as oncology nurse specialists. Our hospital has 17 certified nurse specialists in 4 fields and 41 certified nurses in 10 fields, who have become role models in clinical practice (Table 1).

 We provided career support for two students to enter a master's program in nursing and to take an educational course for certified nursing administrators.

Future Prospects

 We need to provide high-quality cancer nursing and to secure human resources with the aim of promoting team medical care, medical cooperation, regional collaboration, and human resource development in our role as a leading cancer center hospital.

 We aim to respond to various needs of cancer patients and their families, build a support system with interdisciplinary teams and nurses, analyze activity results, and promote prospective studies to build evidence for cancer nursing.

 We would like to take a positive view of the impact of COVID-19 and create an organization that can flexibly respond and solve problems.

Table 1. Number of registered certified nurse specialists and certified nurses
Table 1. Number of registered certified nurse specialists and certified nurses

Table 1. Number of registered certified nurse specialists and certified nurses
Table 1. Number of registered certified nurse specialists and certified nurses

Table 2. Support status of human resources development
Table 2. Support status of human resources development

Table 2. Support status of human resources development
Table 2. Support status of human resources development

List of papers published in 2020

Journal

1. Zenda S, Ryu A, Takashima A, Arai M, Takagi Y, Miyaji T, Mashiko T, Shimizu Y, Yamazaki N, Morizane C, Yamaguchi T, Kawaguchi T, Hanai A, Uchitomi Y, Oshiba F. Hydrocolloid dressing as a prophylactic use for hand-foot skin reaction induced by multitargeted kinase inhibitors: protocol of a phase 3 randomised self-controlled study. BMJ Open, 10:e038276, 2020

2. Matsuoka YJ, Okubo R, Shimizu Y, Tsuji K, Narisawa T, Sasaki J, Sasai H, Akashi-Tanaka S, Hamaguchi T, Iwasa T, Iwata S, Kato T, Kurotani K, Maruyama D, Mori A, Ogawa A, Sakurai N, Shimazu T, Shimizu C, Tabuchi T, Takahashi M, Takano T, Tatematsu N, Uchitomi Y, Watanabe C, Fukui T. Developing the structure of Japan's cancer survivorship guidelines using an expert panel and modified Delphi method. J Cancer Surviv, 14:273-283, 2020